INVIVO THERAPEUTICS HOLDINGS CORP. 5
5 · INVIVO THERAPEUTICS HOLDINGS CORP. · Filed Jan 22, 2016
Insider Transaction Report
Form 5
Ulich Thomas R
Chief Scientific Officer
Transactions
- Award
Common Stock
2015-12-31$6.12/sh+265$1,622→ 21,693 total
Footnotes (1)
- [F1]These shares were acquired under the Issuer's Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).